Shanghai New Pulse Medical Technology
PrivateLast Round
Series C
Mar 25, 2021
Est. Valuation
$713M
Total Funding Raised
$135.92M
Company Overview
Shanghai New Pulse Medical Technology operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series C round in March 2021.
Shanghai New Pulse Medical Technology is a medical device company that specializes in the research, development, and industrialization of artificial heart valves and transcatheter implantation systems.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai New Pulse Medical Technology Comparables
Compare Shanghai New Pulse Medical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitrAssist Lifesciences Limited | 90% | |
| KingstronBio | 86% | |
| Peijia Medical | 85% |
For institutional investors. Book with your work email.
Shanghai New Pulse Medical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 25, 2021 | ||||
| Series B Extension | Apr 15, 2020 | ||||
| Series B | Mar 3, 2020 | ||||
| Series A Extension | Jul 1, 2018 | ||||
| Series A | Apr 4, 2018 | ||||
Pre Seed | Jan 1, 2016 |
For institutional investors. Book with your work email.
Shanghai New Pulse Medical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series C |
| Temasek | Series C |
| Boyuan Capital | Series C |
| LYFE Capital | Series A |
| CBC Group | Series C |
| OrbiMed | Series C, Series B Extension, Series B |
| Shenzhen Dachen Caizhi Venture Capital Management | Series C, Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Pipeline includes TMVR and ventricular assist products.
- Mar 1, 2026
Obtained 9 certificates for valve systems and accessory products.
For institutional investors. Book with your work email.
Shanghai New Pulse Medical Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai New Pulse Medical Technology's valuation, stock price, and market status.
Is Shanghai New Pulse Medical Technology a public or private company?
Shanghai New Pulse Medical Technology is a private company.
What is the current stock price of Shanghai New Pulse Medical Technology?
Shanghai New Pulse Medical Technology is a private company, so its shares have no public market price. Caplight tracks Shanghai New Pulse Medical Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai New Pulse Medical Technology worth (valuation)?
Shanghai New Pulse Medical Technology's valuation is estimated at $713.0M based on funding round data.
Can I buy Shanghai New Pulse Medical Technology stock?
Shanghai New Pulse Medical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai New Pulse Medical Technology's last funding round?
Shanghai New Pulse Medical Technology's most recent funding round was Series C on March 25, 2021.
Who are the main investors in Shanghai New Pulse Medical Technology?
Key investors in Shanghai New Pulse Medical Technology include Temasek, LYFE Capital, OrbiMed, Yunfeng Capital.
Will Shanghai New Pulse Medical Technology IPO soon?
No public IPO plans have been announced for Shanghai New Pulse Medical Technology.
How can I track Shanghai New Pulse Medical Technology secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai New Pulse Medical Technology's shares on secondary markets.